Multisite neuroimaging trials

Current Opinion in Neurology

Volumn 22, Issue 4, 2009, Pages 370-378

  Van Horn, John Darrell ^a   Toga, Arthur W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Clinical trials; Collaboration; Consortia; Data sharing; Multicenter; Neuroimaging

Indexed keywords

BIOLOGICAL MARKER;

ALZHEIMER DISEASE; BRAIN CANCER; BRAIN FUNCTION; BRAIN MAPPING; CLINICAL RESEARCH; COGNITION; FETAL ALCOHOL SYNDROME; HUMAN; INFORMATION PROCESSING; INFORMATION STORAGE; MULTICENTER STUDY; NERVE PROJECTION; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; REVIEW; TISSUE STRUCTURE; TREATMENT OUTCOME; TREATMENT PLANNING; TREND STUDY;

BRAIN DISEASES; CLINICAL TRIALS AS TOPIC; COOPERATIVE BEHAVIOR; DATABASES, FACTUAL; HUMANS; MAGNETIC RESONANCE IMAGING; MULTICENTER STUDIES AS TOPIC;

EID: 68449090706     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/WCO.0b013e32832d92de     Document Type: Review

References (49)

1. Malhi GS, Lagopoulos J. Making sense of neuroimaging in psychiatry. Acta Psychiatr Scand 2008; 117:100-117.
2. Dickerson BC. Advances in functional magnetic resonance imaging: technology and clinical applications. Neurotherapeutics 2007; 4:360-370.
3. Wishart HA, Saykin AJ, McAllister TW. Functional magnetic resonance imaging: emerging clinical applications. Curr Psychiatry Rep 2002; 4:338-345.
4. Small GW, Kepe V, Ercoli LM, et al. PET of brain amyloid and tau in mild cognitive impairment. N Engl J Med 2006; 355:2652-2663.
5. Chertkow H, Black S. Imaging biomarkers and their role in dementia clinical trials. Can J Neurol Sci 2007; 34:77-83.
6. Hariri AR, Weinberger DR. Imaging genomics. Br Med Bull 2003; 65:259-270.
7. Friedman L, Glover GH, Krenz D, Magnotta V. Reducing inter-scanner variability of activation in a multicenter fMRI study: role of smoothness equalization. Neuroimage 2006; 32:1656-1668.
8. Friedman L, Glover GH. Report on a multicenter fMRI quality assurance protocol. J Magn Reson Imaging 2006; 23:827-839.
9. Zhou Z, Liu BJ. HIPAA compliant auditing system for medical images. Comput Med Imaging Graph 2005; 29:235-241.
10. Keator DB, Grethe JS, Marcus D, et al. A national human neuroimaging collaboratory enabled by the Biomedical Informatics Research Network (BIRN). IEEE Trans Inf Technol Biomed 2008; 12:162-172.
11. Smith K, Jajodia S, Swarup V, et al. Enabling the sharing of neuroimaging data through well defined intermediate levels of visibility. Neuroimage 2004; 22:1646-1656.
12. Rex DE, Ma JQ, Toga AW. The LONI pipeline processing environment. Neuroimage 2003; 19:1033-1048.
13. Temal L, Dojat M, Kassel G, Gibaud B. Towards an ontology for sharing medical images and regions of interest in neuroimaging. J Biomed Inform 2008; 41:766-778.
14. Wardlaw JM, Bath P, Sandercock P, et al. The Neuro Grid stroke exemplar clinical trial protocol. Int J Stroke 2007; 2:63-69.
15. Boyes RG, Gunter JL, Frost C, et al. Intensity nonuniformity correction using N3 on 3-T scanners with multichannel phased array coils. Neuroimage 2008; 39:1752-1762; ADNI Study.
16. Jack CR Jr, Bernstein MA, Fox NC, et al. The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods. J Magn Reson Imaging 2008; 27:685-691.
17. Yanovsky I, Thompson PM, Osher S, et al. Validating unbiased registration on longitudinal MRI scans from the Alzheimer's Disease Neuroimaging Initiative (ADNI). In: 5th IEEE International Symposium on Biomedical Imaging: from Nano to Macro; 14-17 May 2008; Paris, France: IEEE; 2008.
18. Morra JH, Tu Z, Apostolova LG, et al. The Alzheimer's Disease Neuroimaging Initiative. Validation of a fully automated 3D hippocampal segmentation method using subjects with Alzheimer's disease mild cognitive impairment, and elderly controls. Neuroimage 2008; 43:59-68.
19. Hua X, Leow AD, Parikshak N, et al. The Alzheimer's Disease Neuroimaging Initiative. Tensor-based morphometry as a neuroimaging biomarker for Alzheimer's disease: an MRI study of 676 AD, MCI, and normal subjects. Neuroimage 2008; 43:458-469.
20. Fletcher PT, Powell S, Foster NL, Joshi SC. Quantifying metabolic asymmetry modulo structure in Alzheimer's disease. Inf Process Med Imaging 2007; 20:446-457.
21. Leow AD, Klunder AD, Jack CR Jr, et al. Longitudinal stability of MRI for mapping brain change using tensor-based morphometry. Neuroimage 2006; 31:627-640;
22. Mueller SG, Weiner MW, Thal LJ, et al. Ways toward an early diagnosis in Alzheimer's disease: the Alzheimer's Disease Neuroimaging Initiative (ADNI). Alzheimers Dement 2005; 1:55-66.
23. Moore ES, Ward RE, Wetherill LF, et al. Unique facial features distinguish fetal alcohol syndrome patients and controls in diverse ethnic populations. Alcohol Clin Exp Res 2007; 31:1707-1713;
24. Mazziotta JC, Woods R, Iacoboni M, et al. The myth of the normal, average human brain: the ICBM experience: (1) subject screening and eligibility. Neuroimage 2009; 44:914-922.
25. Mazziotta J, Toga AW, Evans A, et al. A probabilistic atlas and reference system for the human brain: International Consortium for Brain Mapping (ICBM). Philos Trans R Soc Lond B Biol Sci 2001; 356:1293-1322.
26. Mazziotta JC, Toga AW, Evans A, et al. A probabilistic atlas of the human brain: theory and rationale for its development. The International Consortium for Brain Mapping (ICBM). Neuroimage 1995; 2:89-101.
27. Kim DI, Mathalon DH, Ford JM, et al. Auditory oddball deficits in schizophrenia: an independent component analysis of the fMRI multisite function BIRN Study. Schizophr Bull 2009; 35:67-81.
28. Potkin SG, Ford JM. Widespread cortical dysfunction in schizophrenia: the FBIRN Imaging Consortium. Schizophr Bull 2009; 35:15-18.
29. Friedman L, Stern H, Brown GG, et al. Test-retest and between-site reliability in a multicenter fMRI study. Hum Brain Mapp 2008; 29:958-972.
30. Mulkern RV, Forbes P, Dewey K, et al. Establishment and results of a magnetic resonance quality assurance program for the pediatric brain tumor consortium. Acad Radiol 2008; 15:1099-1110.
31. Poussaint TY, Phillips PC, Vajapeyam S, et al. The Neuroimaging Center of the Pediatric Brain Tumor Consortium-collaborative neuroimaging in pediatric brain tumor research: a work in progress. AJNR Am J Neuroradiol 2007; 28:603-607.
32. Fennema-Notestine C, Gamst AC, Quinn BT, et al. Feasibility of multisite clinical structural neuroimaging studies of aging using legacy data. Neuroinformatics 2007; 5:235-245.
33. Gururangan S, Turner CD, Stewart CF, et al. Phase I trial of VNP40101M (Cloretazine) in children with recurrent brain tumors: a pediatric brain tumor consortium study. Clin Cancer Res 2008; 14:1124-1130.
34. Hampel H, Burger K, Teipel SJ, et al. Core candidate neurochemical and imaging biomarkers of Alzheimer's disease. Alzheimers Dement 2008; 4:38-48.
35. Frisoni GB, Henneman WJ, Weiner MW, et al. The pilot European Alzheimer's Disease Neuroimaging Initiative of the European Alzheimer's Disease Consortium. Alzheimers Dement 2008; 4:255-264.
36. Van Horn J, Bandettini P, Cheng K, et al. New horizons for the next era of human brain imaging, cognitive, and behavioral research: Pacific Rim interactivity. Brain Imaging Behav 2008; 2:227-231.
37. Grady C, Strother S. Pacific Rim collaborations: a Canadian perspective. Brain Imaging Behav 2008; 2:359-363.
38. Hall HI, Song R, Rhodes P, et al. Estimation of HIV incidence in the United States. JAMA 2008; 300:520-529;
39. Hult B, Chana G, Masliah E, Everall I. Neurobiology of HIV. Int Rev Psychiatry 2008; 20:3-13.
40. Chiang M-C, Dutton RA, Hayashi KM, et al. 3D pattern of brain atrophy in HIV/AIDS visualized using tensor-based morphometry. Neuroimage 2007; 34:44-60.
41. Thompson PM, Dutton RA, Hayashi KM, et al. 3D mapping of ventricular and corpus callosum abnormalities in HIV/AIDS. Neuroimage 2006; 31:12-23.
42. Lee PL, Yiannoutsos CT, Ernst T, et al. A multicenter 1H MRS study of the AIDS dementia complex: validation and preliminary analysis. J Magn Reson Imaging 2003; 17:625-633;
43. Toga AW. The Laboratory of Neuro Imaging: what it is, why it is, and how it came to be. IEEE Trans Med Imaging 2002; 21:1333-1343.
44. MacKenzie-Graham A, Payan A, Dinov I, et al. Neuroimaging data provenance using the LONI pipeline workflow environment. In: Provenance and Annotation of Data International Provenance and Annotation Workshop, IPAW 2008. Moreau L, Foster I, editors; Salt Lake City, Utah. University of Utah; 2008.
45. Toga AW. Imaging databases and neuroscience. Neuroscientist 2002; 8:423-436.
46. Van Horn JD, Dobson J, Woodward J, et al. Grid-based computing and the future of neuroscience computation. In: Senior C, Russell T, Gazzaniga MS, editors. Methods in Mind. Cambridge, MA: MIT Press; 2006. pp. 141-170.
47. Rosen BR, Buckner RL, Dale A. Event-related functional MRI: past, present, and future. Proc Natl Acad Sci U S A 1998; 95:773-780.
48. Raichle ME. Functional neuroimaging: a historical and physiological perspective. In: Cabeza R, Kingstone A, editors. Handbook of functional neuroimaging of cognition. Cambridge, MA: MIT Press; 2001. pp. 3-26.
49. Toga AW, Thompson PM. Maps of the brain. Anat Rec 2001; 265:37-53.